109 related articles for article (PubMed ID: 27641756)
1. WITHDRAWN: C1qTNF related protein 4 (CTRP4) promotes pancreatic ductal adenocarcinoma cell proliferation and migration via activation of EGFR-PI3K-NF-κB pathway.
Fan H; Zhang M; Li S; Wu J
Oncol Res; 2016 Sep; ():. PubMed ID: 27641756
[TBL] [Abstract][Full Text] [Related]
2. C1q/TNF-related protein 4 restores leptin sensitivity by downregulating NF-κB signaling and microglial activation.
Ye L; Jia G; Li Y; Wang Y; Chen H; Yu L; Wu D
J Neuroinflammation; 2021 Jul; 18(1):159. PubMed ID: 34275474
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer.
Hua Q; Li T; Liu Y; Shen X; Zhu X; Xu P
Front Oncol; 2021; 11():624837. PubMed ID: 34395235
[TBL] [Abstract][Full Text] [Related]
4. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
[TBL] [Abstract][Full Text] [Related]
5. Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling.
Kuo SH; Yang SH; Wei MF; Lee HW; Tien YW; Cheng AL; Yeh KH
Cancer Cell Int; 2021 Aug; 21(1):436. PubMed ID: 34412631
[TBL] [Abstract][Full Text] [Related]
6. Identification of C1qTNF-related protein 4 as a potential cytokine that stimulates the STAT3 and NF-κB pathways and promotes cell survival in human cancer cells.
Li Q; Wang L; Tan W; Peng Z; Luo Y; Zhang Y; Zhang G; Na D; Jin P; Shi T; Ma D; Wang L
Cancer Lett; 2011 Sep; 308(2):203-14. PubMed ID: 21658842
[TBL] [Abstract][Full Text] [Related]
7. TNFR2 promotes pancreatic cancer proliferation, migration, and invasion via the NF-κB signaling pathway.
Gao Z; Zhang Q; Chen H; Chen J; Kang J; Yu H; Song Y; Zhang X
Aging (Albany NY); 2023 Aug; 15(16):8013-8025. PubMed ID: 37589506
[TBL] [Abstract][Full Text] [Related]
8. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
9. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
10. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
11. Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma.
Wang Y; Wang D; Dai Y; Kong X; Zhu X; Fan Y; Wang Y; Wu H; Jin J; Yao W; Gao J; Wang K; Xu H
Front Oncol; 2021; 11():652283. PubMed ID: 34046348
[TBL] [Abstract][Full Text] [Related]
12. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway.
Ding M; Liu J; Lv H; Zhu Y; Chen Y; Peng H; Fan S; Chen X
Front Oncol; 2023; 13():1097772. PubMed ID: 36925932
[TBL] [Abstract][Full Text] [Related]
13. PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway.
Tang D; Zhang J; Yuan Z; Zhang H; Chong Y; Huang Y; Wang J; Xiong Q; Wang S; Wu Q; Tian Y; Lu Y; Ge X; Shen W; Wang D
Oncotarget; 2017 Oct; 8(49):86488-86502. PubMed ID: 29156810
[TBL] [Abstract][Full Text] [Related]
14. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
[TBL] [Abstract][Full Text] [Related]
15. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.
Li S; Hong H; Lv H; Wu G; Wang Z
Med Sci Monit; 2016 May; 22():1593-600. PubMed ID: 27170223
[TBL] [Abstract][Full Text] [Related]
16. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.
Luo Z; Yi ZJ; Ou ZL; Han T; Wan T; Tang YC; Wang ZC; Huang FZ
J Cell Physiol; 2019 Apr; 234(4):3583-3597. PubMed ID: 30362505
[TBL] [Abstract][Full Text] [Related]
17. miR-499a promotes PANC-1 cell proliferation by down-regulating PDCD4 expression in pancreatic ductal adenocarcinoma.
Bao J; Li Z
Int J Clin Exp Pathol; 2020; 13(6):1390-1396. PubMed ID: 32661474
[TBL] [Abstract][Full Text] [Related]
18. PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells.
Shah SA; Potter MW; Hedeshian MH; Kim RD; Chari RS; Callery MP
J Gastrointest Surg; 2001; 5(6):603-12; discussion 612-3. PubMed ID: 12086898
[TBL] [Abstract][Full Text] [Related]
19. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells.
Stock K; Borrink R; Mikesch JH; Hansmeier A; Rehkämper J; Trautmann M; Wardelmann E; Hartmann W; Sperveslage J; Steinestel K
Cancer Cell Int; 2019; 19():77. PubMed ID: 30976201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
